EUVIMEDOpdag EUVIMED
Multizentrische StudieOpen access · CC BY-NC 4.0

Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick‐borne encephalitis disease severity—a multicentre study on Lithuanian and Swedish patients

Malin Veje iD, Vytautas Griška, Jolita Pakalnienė iD, Auksė Mickienė, Daniel Bremell iD, Henrik Zetterberg, Kaj Blennow, Lars Lindquist, Marie Studahl

European Journal of Neurology · 2023-10 · 30 (10) · 3182-3189

DOI: 10.1111/ene.15978 ↗

At a glance

Multizentrische Studie in European Journal of Neurology, published online on 2023-07-23. Written by Malin Veje and 8 co-authors. Institution: Institute of Biomedicine, Department of Infectious Diseases, Sahlgrenska Academy at the Gothenburg University, Gothenburg, Sweden. Major MEDLINE topics: Encephalitis, Tick-Borne, Brain Injuries. Cited 17 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Alzheimer's Association, Alzheimer's Drug Discovery Foundation, European Society of Clinical Microbiology and Infectious Diseases.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and purpose Our aim was to examine the correlation between biomarkers of neuronal and glial cell damage and severity of disease in patients with tick‐borne encephalitis.

Methods

One hundred and fifteen patients with tick‐borne encephalitis diagnosed in Lithuania and Sweden were prospectively included, and cerebrospinal fluid (CSF) and serum samples were obtained shortly after hospitalization. Using pre‐defined criteria, cases were classified as mild, moderate or severe tick‐borne encephalitis. Additionally, the presence of spinal nerve paralysis (myelitis) and/or cranial nerve affection were noted. Concentrations of the brain cell biomarkers glial fibrillary acidic protein (GFAP), YKL‐40, S100B, neurogranin, neurofilament light (NfL) and tau were analysed in CSF and, in addition, NfL, GFAP and S100B levels were measured in serum. The Jonckheere‐Terpstra test was used for group comparisons of continuous variables and Spearman's partial correlation test was used to adjust for age.

Results

Cerebrospinal fluid and serum concentrations of GFAP and NfL correlated with disease severity, independent of age, and with the presence of nerve paralysis. The markers neurogranin, YKL‐40, tau and S100B in CSF and S100B in serum were detected, but their concentrations did not correlate with disease severity.

Conclusions

Neuronal cell damage and astroglial cell activation with increased NfL and GFAP in CSF and serum were associated with a more severe disease, independent of age. Increased GFAP and NfL concentrations in CSF and NfL in serum were also indicative of spinal and/or cranial nerve damage. NfL and GFAP are promising prognostic biomarkers in tick‐borne encephalitis, and future studies should focus on determining the association between these biomarkers and long‐term sequelae.

Subjects

MeSH terms (MEDLINE)

Encephalitis, Tick-BorneBrain InjuriesHumansChitinase-3-Like Protein 1LithuaniaSwedenGlial Fibrillary Acidic ProteinIntermediate FilamentsNeurograninBiomarkersBrainPatient AcuityNeurofilament Proteins

Author keywords

central nervous systemneurofilamentneurogliatick-borne encephalitisviral encephalitis

Substances

Chitinase-3-Like Protein 1Glial Fibrillary Acidic ProteinNeurograninBiomarkersNeurofilament Proteins

Authors and institutions

  • Institute of Biomedicine, Department of Infectious Diseases, Sahlgrenska Academy at the Gothenburg University, Gothenburg, Sweden.
  • Region Västra Götaland, Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Infectious Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
  • Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
  • Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.

ORCID profiles: Malin Veje, Jolita Pakalnienė, Daniel Bremell

Funding

  • Alzheimer's Association
  • Alzheimer's Drug Discovery Foundation
  • European Society of Clinical Microbiology and Infectious Diseases
  • European Commission
  • Hjärnfonden
  • Pfizer
  • Stiftelsen för Gamla Tjänarinnor
  • UK Dementia Research Institute

Cite

APA

Veje, M., Griška, V., Pakalnienė, J., Mickienė, A., Bremell, D., Zetterberg, H., Blennow, K., Lindquist, L., & Studahl, M. (2023). Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick‐borne encephalitis disease severity—a multicentre study on Lithuanian and Swedish patients. European Journal of Neurology, 30(10), 3182-3189. https://doi.org/10.1111/ene.15978

Vancouver

Veje M, Griška V, Pakalnienė J, Mickienė A, Bremell D, Zetterberg H, et al. Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick‐borne encephalitis disease severity—a multicentre study on Lithuanian and Swedish patients. European Journal of Neurology. 2023;30(10):3182-3189. doi:10.1111/ene.15978

BibTeX
@article{Veje2023,
  author = {Veje, Malin and Griška, Vytautas and Pakalnienė, Jolita and Mickienė, Auksė and Bremell, Daniel and Zetterberg, Henrik and Blennow, Kaj and Lindquist, Lars and Studahl, Marie},
  title = {Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick‐borne encephalitis disease severity—a multicentre study on Lithuanian and Swedish patients},
  journal = {European Journal of Neurology},
  year = {2023},
  volume = {30},
  number = {10},
  pages = {3182--3189},
  doi = {10.1111/ene.15978}
}
Start for free →